title: Immunization with a recombinant GnRH vaccine fused to heat shock protein 65 inhibits mammary tumor growth in vivo.
abstract: Gonadotrophin-releasing hormone (GnRH) is the prime decapeptide hormone in the regulation of mammalian reproduction. Active immunization against GnRH has been a good treatment option to fight against hormone-dependent disease such as breast cancer. We designed and purified a novel protein vaccine Hsp65-GnRH(6) containing heat shock protein 65 (Hsp65) and six copies of GnRH in linear alignment. Immunization with Hsp65-GnRH(6) evoked strong humoral response in female mice. The generation of specific anti-GnRH antibodies was detected by ELISA and verified by western blot. In addition, anti-GnRH antibodies effectively neutralized endogenous GnRH activity in vivo, as demonstrated by the degeneration of the ovaries and uteri in the vaccinated mice. Moreover, the growth of EMT-6 mammary tumor allografts was inhibited by anti-GnRH antibodies. Histological examinations have shown that there was increased focal necrosis in tumors. Taken together, our results showed that immunization with Hsp65-GnRH(6) elicited high titer of specific anti-GnRH antibodies and further led to atrophy of reproductive organs. The specific antibodies could inhibit the growth of EMT-6 murine mammary tumor probably via an indirect mechanism that includes the depletion of estrogen. In view of these results, the protein vaccine Hsp65-GnRH(6) appears to be a promising candidate vaccine for hormone-dependent cancer therapy.
authors.affiliation: Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University, Hanzhong Road 140, Nanjing, 210029, China. wangxuejun1979728@hotmail.com
authors.forename: Xue Jun
authors.initials: XJ
authors.lastname: Wang
authors.forename: Kai
authors.initials: K
authors.lastname: Gu
authors.forename: Jin Shu
authors.initials: JS
authors.lastname: Xu
authors.forename: Ming Hui
authors.initials: MH
authors.lastname: Li
authors.forename: Rong Yue
authors.initials: RY
authors.lastname: Cao
authors.forename: Jie
authors.initials: J
authors.lastname: Wu
authors.forename: Tai Ming
authors.initials: TM
authors.lastname: Li
authors.forename: Jing Jing
authors.initials: JJ
authors.lastname: Liu
mesh_terms: D000818:Animals; D001426:Bacterial Proteins / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology*; D018834:Chaperonin 60 / Q000276:immunology*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000276:immunology*; D007114:Immunization; D008325:Mammary Neoplasms, Experimental / Q000473:pathology / Q000628:therapy*; D051379:Mice; D008807:Mice, Inbred BALB C; D014614:Vaccines, Synthetic / Q000276:immunology
chemical_list: D001426:Bacterial Proteins; D019496:Cancer Vaccines; D018834:Chaperonin 60; D014614:Vaccines, Synthetic; C074119:heat-shock protein 65, Mycobacterium; D007987:Gonadotropin-Releasing Hormone
references.citation: Protein Expr Purif. 2006 Dec;50(2):163-70
references.pmid: 17064933
references.citation: Vaccine. 2010 Jul 12;28(31):4984-8
references.pmid: 20639128
references.citation: Vaccine. 2007 Sep 28;25(39-40):6911-21
references.pmid: 17728021
references.citation: Vaccine. 2007 May 30;25(22):4478-86
references.pmid: 17467856
references.citation: Front Neuroendocrinol. 2009 Jan;30(1):10-29
references.pmid: 18708085
references.citation: Endocrinology. 2006 Jan;147(1):571-9
references.pmid: 16223868
references.citation: Trends Endocrinol Metab. 2009 Jan;20(1):43-50
references.pmid: 19008119
references.citation: Proc Natl Acad Sci U S A. 1982 Sep;79(17):5392-5
references.pmid: 6752946
references.citation: Eur J Cancer. 1997 Aug;33(9):1468-78
references.pmid: 9337691
references.citation: J Neuroendocrinol. 2008 Jun;20(6):719-26
references.pmid: 18601694
references.citation: Br J Cancer. 1999 May;80(3-4):352-9
references.pmid: 10408837
references.citation: Curr Cancer Drug Targets. 2007 May;7(3):229-41
references.pmid: 17504120
references.citation: Endocr Relat Cancer. 2003 Jun;10(2):291-9
references.pmid: 12790790
references.citation: Endocr Relat Cancer. 2008 Mar;15(1):149-59
references.pmid: 18310283
references.citation: Neuroendocrinology. 2009;90(3):235-44
references.pmid: 19602868
references.citation: Vaccine. 2007 Dec 5;25(50):8460-8
references.pmid: 18022737
references.citation: Vaccine. 2009 Dec 9;27(52):7377-84
references.pmid: 19778518
references.citation: Cancer Res. 2000 Jul 15;60(14):3701-5
references.pmid: 10919636
references.citation: J Immunol Methods. 2004 Jun;289(1-2):111-22
references.pmid: 15251417
references.citation: Br J Cancer. 2000 Aug;83(4):443-6
references.pmid: 10945488
references.citation: Endocrinology. 2003 Jul;144(7):3262-9
references.pmid: 12810583
references.citation: Endocr Rev. 1986 Feb;7(1):95-105
references.pmid: 3007081
references.citation: Cancer Lett. 2008 Feb 8;259(2):240-50
references.pmid: 18039558
references.citation: Expert Opin Investig Drugs. 2009 Jun;18(6):851-60
references.pmid: 19453267